Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model. [PDF]
, 1990 D Collen +4 more
openalex +1 more source
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients. [PDF]
Int J Mol Sci, 2023 Gavriilaki E +18 more
europepmc +1 more source
Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas. [PDF]
Cancers (Basel), 2023 Peng L +12 more
europepmc +1 more source
Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression [PDF]
, 1997 Korsa Khan, Domenick J. Falcone
openalex +1 more source
Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors [PDF]
, 1999 Sanjeeva Mohanam +3 more
openalex +1 more source
Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. [PDF]
Sci Rep, 2023 Risør LM +6 more
europepmc +1 more source
Binding of urokinase-type plasminogen activator–plasminogen activator inhibitor-1 complex to the endocytosis receptors α2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor [PDF]
, 1998 W. Kees RODENBURG +3 more
openalex +1 more source
Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. [PDF]
Sci Rep, 2022 Risør LM +6 more
europepmc +1 more source